Allergic contact dermatitis caused by a new insulin pump system containing isobornyl acrylate
Contact Dermatitis · 2023
DOI: 10.1111/cod.14274 ↗At a glance
Fallbericht in Contact Dermatitis, 2023. Written by Johanna Enberg and 2 co-authors. Institution: Department of Occupational and Environmental Dermatology, Lund University, Skåne University Hospital, Malmö, Sweden. Major MEDLINE topics: Dermatitis, Allergic Contact, Insulins. Cited 12 times so far (Crossref); 10 references.
Abstract (original language)
Ebda abstract disponibbli.
Subjects
MeSH terms (MEDLINE)
Author keywords
Substances
Authors and institutions
- Department of Occupational and Environmental Dermatology, Lund University, Skåne University Hospital, Malmö, Sweden.
- Helsingborg's Hospital, Helsingborg, Sweden.
ORCID profiles: Johanna Enberg, Nils Hamnerius, Martin Mowitz
Cite
APA
Enberg, J., Hamnerius, N., & Mowitz, M. (2023). Allergic contact dermatitis caused by a new insulin pump system containing isobornyl acrylate. Contact Dermatitis. https://doi.org/10.1111/cod.14274
Vancouver
Enberg J, Hamnerius N, Mowitz M. Allergic contact dermatitis caused by a new insulin pump system containing isobornyl acrylate. Contact Dermatitis. 2023. doi:10.1111/cod.14274
BibTeX
@article{Enberg2023,
author = {Enberg, Johanna and Hamnerius, Nils and Mowitz, Martin},
title = {Allergic contact dermatitis caused by a new insulin pump system containing isobornyl acrylate},
journal = {Contact Dermatitis},
year = {2023},
doi = {10.1111/cod.14274}
}
EUVIMED